$CTIC Company News
Post# of 89310
Posted On: 05/19/2014 10:29:44 AM
$CTIC Company News
Insider filings one way to track tricky micro-cap biotechs
12:14 p.m. Oct. 24, 2012
- blogs.marketwatch.com
Friday’s biggest gaining and declining stocks
4:27 p.m. Oct. 5, 2012
- Greg Morcroft
Cell Therapeutics down 21% in premarket
7:15 a.m. Oct. 5, 2012
- Steve Gelsi
Tuesday’s biggest gaining and declining stocks
4:53 p.m. Oct. 2, 2012
- MarketWatch
Cell Therapeutics up 21% in premarket
8:38 a.m. Oct. 2, 2012
- Steve Gelsi
CTIC gets orphan drug status for brain cancer drug
7:37 a.m. Oct. 2, 2012
- MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug
6:59 a.m. Sept. 24, 2012
- MarketWatch.com
Tuesday’s top gaining and declining stocks
4:57 p.m. Sept. 11, 2012
- MarketWatch
Cell Therapeutics soars 24% on EU drug launch
10:12 a.m. Sept. 11, 2012
- Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks
5:01 p.m. Sept. 4, 2012
- Greg Morcroft
Updates, advisories and surprises
5:01 p.m. July 31, 2012
- MarketWatch
Cell Therapeutics announces stock placement
11:45 a.m. July 31, 2012
- Val Brickates Kennedy
Friday’s biggest gaining and declining stocks
5:21 p.m. Feb. 17, 2012
- Kate Gibson
Monday’s biggest gaining and declining stocks
5:49 p.m. Jan. 30, 2012
- Kate Gibson
Cell Therapeutics pulls application; shares slump
2:25 p.m. Jan. 30, 2012
- MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper
5:35 p.m. Dec. 9, 2011
- William Spain
Friday’s biggest gaining & declining stocks
5:35 p.m. Dec. 9, 2011
- Kate Gibson
Thursday’s biggest gaining & declining stocks
4:59 p.m. June 30, 2011
- Kate Gibson
Cell Therapeutics tumbles over offerings
9:09 a.m. June 30, 2011
- MarketWatch.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack
6:00 a.m. May 9, 2014
- TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None
9:10 a.m. May 7, 2014
- Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript
10:52 p.m. April 29, 2014
- Seeking Alpha
10-Q: CELL THERAPEUTICS INC
5:10 p.m. April 29, 2014
- Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape
9:21 a.m. April 29, 2014
- Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape
9:21 a.m. April 10, 2014
- Zacks.com
Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders
10:45 a.m. March 31, 2014
- TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape
9:30 a.m. March 28, 2014
- Zacks.com
First Week Of CTIC May 17th Options Trading
12:54 p.m. March 26, 2014
- TheStreet.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month
10:39 a.m. March 24, 2014
- Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ...
10:12 a.m. March 24, 2014
- GuruFocus.com
Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns
9:57 a.m. March 12, 2014
- TheStreet.com
Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders
1:16 p.m. March 10, 2014
- TheStreet.com
Is It Too Late to Buy the Rally in Small Caps?
12:00 a.m. March 7, 2014
- InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript
9:21 p.m. March 4, 2014
- Seeking Alpha
10-K: CELL THERAPEUTICS INC
5:32 p.m. March 4, 2014
- Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment
4:49 p.m. March 4, 2014
- Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation
9:47 a.m. Feb. 27, 2014
- Seeking Alpha
Interesting CTIC Put And Call Options For April 19th
11:01 a.m. Feb. 26, 2014
- TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule
7:33 a.m. Feb. 26, 2014
- TheStreet.com
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma
9:15 a.m. May 6, 2014
- PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results
4:01 p.m. April 29, 2014
- PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
1:30 a.m. April 29, 2014
- PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014
1:30 a.m. April 22, 2014
- PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America
8:55 a.m. March 25, 2014
- PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics
8:00 a.m. March 18, 2014
- PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx
8:54 a.m. March 14, 2014
- PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference
2:30 a.m. March 5, 2014
- PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
5:00 p.m. March 4, 2014
- PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts
2:30 a.m. March 3, 2014
- PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone)
2:30 a.m. Feb. 27, 2014
- PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014
2:30 a.m. Feb. 25, 2014
- PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million
10:17 a.m. Feb. 24, 2014
- ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC)
11:12 a.m. Feb. 11, 2014
- ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors
2:30 a.m. Feb. 3, 2014
- PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia
2:30 a.m. Jan. 30, 2014
- PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer
2:30 a.m. Jan. 28, 2014
- PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC)
8:23 a.m. Jan. 20, 2014
- ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources
11:52 a.m. Jan. 14, 2014
- ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress
2:30 a.m. Jan. 14, 2014
- PR Newswire - PRF
Insider filings one way to track tricky micro-cap biotechs
12:14 p.m. Oct. 24, 2012
- blogs.marketwatch.com
Friday’s biggest gaining and declining stocks
4:27 p.m. Oct. 5, 2012
- Greg Morcroft
Cell Therapeutics down 21% in premarket
7:15 a.m. Oct. 5, 2012
- Steve Gelsi
Tuesday’s biggest gaining and declining stocks
4:53 p.m. Oct. 2, 2012
- MarketWatch
Cell Therapeutics up 21% in premarket
8:38 a.m. Oct. 2, 2012
- Steve Gelsi
CTIC gets orphan drug status for brain cancer drug
7:37 a.m. Oct. 2, 2012
- MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug
6:59 a.m. Sept. 24, 2012
- MarketWatch.com
Tuesday’s top gaining and declining stocks
4:57 p.m. Sept. 11, 2012
- MarketWatch
Cell Therapeutics soars 24% on EU drug launch
10:12 a.m. Sept. 11, 2012
- Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks
5:01 p.m. Sept. 4, 2012
- Greg Morcroft
Updates, advisories and surprises
5:01 p.m. July 31, 2012
- MarketWatch
Cell Therapeutics announces stock placement
11:45 a.m. July 31, 2012
- Val Brickates Kennedy
Friday’s biggest gaining and declining stocks
5:21 p.m. Feb. 17, 2012
- Kate Gibson
Monday’s biggest gaining and declining stocks
5:49 p.m. Jan. 30, 2012
- Kate Gibson
Cell Therapeutics pulls application; shares slump
2:25 p.m. Jan. 30, 2012
- MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper
5:35 p.m. Dec. 9, 2011
- William Spain
Friday’s biggest gaining & declining stocks
5:35 p.m. Dec. 9, 2011
- Kate Gibson
Thursday’s biggest gaining & declining stocks
4:59 p.m. June 30, 2011
- Kate Gibson
Cell Therapeutics tumbles over offerings
9:09 a.m. June 30, 2011
- MarketWatch.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack
6:00 a.m. May 9, 2014
- TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None
9:10 a.m. May 7, 2014
- Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript
10:52 p.m. April 29, 2014
- Seeking Alpha
10-Q: CELL THERAPEUTICS INC
5:10 p.m. April 29, 2014
- Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape
9:21 a.m. April 29, 2014
- Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape
9:21 a.m. April 10, 2014
- Zacks.com
Insider Trading Alert - CTIC, KR And IBKR Traded By Insiders
10:45 a.m. March 31, 2014
- TheStreet.com
Zacks Rank #1 Additions for Friday - Tale of the Tape
9:30 a.m. March 28, 2014
- Zacks.com
First Week Of CTIC May 17th Options Trading
12:54 p.m. March 26, 2014
- TheStreet.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month
10:39 a.m. March 24, 2014
- Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ...
10:12 a.m. March 24, 2014
- GuruFocus.com
Geron: FDA Suspends Key Myelofibrosis Drug Due to Liver Safety Concerns
9:57 a.m. March 12, 2014
- TheStreet.com
Insider Trading Alert - CTIC, TCBI And FCS Traded By Insiders
1:16 p.m. March 10, 2014
- TheStreet.com
Is It Too Late to Buy the Rally in Small Caps?
12:00 a.m. March 7, 2014
- InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript
9:21 p.m. March 4, 2014
- Seeking Alpha
10-K: CELL THERAPEUTICS INC
5:32 p.m. March 4, 2014
- Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment
4:49 p.m. March 4, 2014
- Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation
9:47 a.m. Feb. 27, 2014
- Seeking Alpha
Interesting CTIC Put And Call Options For April 19th
11:01 a.m. Feb. 26, 2014
- TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule
7:33 a.m. Feb. 26, 2014
- TheStreet.com
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma
9:15 a.m. May 6, 2014
- PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results
4:01 p.m. April 29, 2014
- PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
1:30 a.m. April 29, 2014
- PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014
1:30 a.m. April 22, 2014
- PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America
8:55 a.m. March 25, 2014
- PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics
8:00 a.m. March 18, 2014
- PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx
8:54 a.m. March 14, 2014
- PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference
2:30 a.m. March 5, 2014
- PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
5:00 p.m. March 4, 2014
- PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts
2:30 a.m. March 3, 2014
- PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone)
2:30 a.m. Feb. 27, 2014
- PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014
2:30 a.m. Feb. 25, 2014
- PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million
10:17 a.m. Feb. 24, 2014
- ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC)
11:12 a.m. Feb. 11, 2014
- ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors
2:30 a.m. Feb. 3, 2014
- PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia
2:30 a.m. Jan. 30, 2014
- PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer
2:30 a.m. Jan. 28, 2014
- PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC)
8:23 a.m. Jan. 20, 2014
- ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources
11:52 a.m. Jan. 14, 2014
- ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress
2:30 a.m. Jan. 14, 2014
- PR Newswire - PRF
(0)
(0)